A comparison of the disease-modifying and cytokine-regulating activities of tenidap, piroxicam and cyclosporin-A using the adjuvant-induced model of arthritis in rats
dc.contributor.author | Haynes, D. | |
dc.contributor.author | Hutchens, M. | |
dc.contributor.author | Whitehouse, M. | |
dc.contributor.author | Vernon-Roberts, B. | |
dc.date.issued | 1998 | |
dc.description.abstract | This study compared the antiarthritic activity of tenidap, piroxicam and cyclosporin-A (CsA) using the model of adjuvant-induced arthritis in rats. The aim of the study was to correlate any disease-modifying effects of tenidap with its in-vivo regulation of cytokines. Both tenidap and piroxicam reduced arthritic disease when administered orally from the time the first signs of arthritis are expressed. Disease suppression correlated with a significant reduction in interleukin-6 production and a slight reduction in interleukin-1 and tumour necrosis factor production. When coadministered with the adjuvant, tenidap and CsA prevented disease in 50% and 100% of animals, respectively, whereas piroxicam had no effect. This disease prevention induced by tenidap and CsA coincided with reduced interferon-γ and interleukin-2 production by lymph node cells one day following initiation of adjuvant disease. This inhibition of T-cell cytokines might be consistent with tenidap acting as a disease-modifying drug. | |
dc.description.statementofresponsibility | D. R. Haynes, M. J. Hutchens, M. W. Whitehouse, B. Vernon-Roberts | |
dc.identifier.citation | Inflammopharmacology: experimental and clinical studies, 1998; 6(3):193-202 | |
dc.identifier.doi | 10.1007/s10787-998-0019-z | |
dc.identifier.issn | 0925-4692 | |
dc.identifier.issn | 1568-5608 | |
dc.identifier.uri | http://hdl.handle.net/2440/5644 | |
dc.language.iso | en | |
dc.publisher | Springer Science and Business Media LLC | |
dc.rights | © Springer, Part of Springer Science+Business Media | |
dc.source.uri | https://doi.org/10.1007/s10787-998-0019-z | |
dc.title | A comparison of the disease-modifying and cytokine-regulating activities of tenidap, piroxicam and cyclosporin-A using the adjuvant-induced model of arthritis in rats | |
dc.type | Journal article | |
pubs.publication-status | Published |